Samuel Rubinstein Net Worth

The estimated Net Worth of Samuel Rubinstein is at least $568 millier dollars as of 20 November 2023. Samuel Rubinstein owns over 1,000 units of STRATA Skin Sciences Inc stock worth over $567,438 and over the last 6 years Samuel sold SSKN stock worth over $320.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Samuel Rubinstein SSKN stock SEC Form 4 insiders trading

Samuel has made over 2 trades of the STRATA Skin Sciences Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently Samuel sold 1,000 units of SSKN stock worth $320 on 20 November 2023.

The largest trade Samuel's ever made was buying 1,050 units of STRATA Skin Sciences Inc stock on 15 June 2022 worth over $1,092. On average, Samuel trades about 256 units every 65 days since 2018. As of 20 November 2023 Samuel still owns at least 177,602 units of STRATA Skin Sciences Inc stock.

You can see the complete history of Samuel Rubinstein stock trades at the bottom of the page.

What's Samuel Rubinstein's mailing address?

Samuel's mailing address filed with the SEC is 100 Lakeside Dr #100, Horsham, PA 19044, USA.

Insiders trading at STRATA Skin Sciences Inc

Over the last 9 years, insiders at STRATA Skin Sciences Inc have traded over $348,780 worth of STRATA Skin Sciences Inc stock and bought 2,664,087 units worth $2,970,754 . The most active insiders traders include Healthcare Master Fund Ltd ..., Lp22 Nw Fund, Lp22 Nw Fund ... et Dolev Rafaeli. On average, STRATA Skin Sciences Inc executives and independent directors trade stock every 127 days with the average trade being worth of $392,199. The most recent stock trade was executed by Uri Geiger on 15 July 2024, trading 230,573 units of SSKN stock currently worth $723,999.

What does STRATA Skin Sciences Inc do?

formerly mela sciences, strata skin sciences is a new company built by unconventional thinkers. a medical technology company that brings hope and help to the dermatology patient in all of us. it’s not just a device or a technology, it’s optimism for psoriasis, determination for improving patients’ lives, and advocacy for getting it right.

Complete history of Samuel Rubinstein stock trades at STRATA Skin Sciences Inc

STRATA Skin Sciences Inc executives and stock owners

STRATA Skin Sciences Inc executives and other stock owners filed with the SEC include:

• Michael R. Stewart,
  Independent Consultant
• Kathryn Swintek,
  Independent Director
• David Stone,
  Independent Director
• Samuel Navarro,
  Independent Director
• Jeffrey O'Donnell,
  Director
• James Coyne,
  Director
• Matthew Hill,
  Chief Financial Officer
• Dolev Rafaeli,
  Interim Chief Executive Officer
• Frank McCaney,
  President, Director
• LuAnn Via,
  Chairman of the Board
• Nikolai Kabelev,
  VP of R&D
• Shmuel Gov,
  Exec. VP & GM
• Dr. Darrell S. Rigel,
  Chief Medical Advisor
• Keith Simeone,
  VP of Sales
• Jay Sturm,
  Gen. Counsel & Corp. Sec.
• Christopher Lesovitz,
  Chief Financial Officer
• Robert J. Moccia,
  Pres, CEO & Director
• William D. Humphries,
  Exec. Chairman
• Healthcare Master Fund Ltd ...,
  
• Michael R Stewart,
  President & CEO
• Richard Rox Anderson,
  Director
• Christina L Allgeier,
  CFO
• David N Gill,
  
• Partners, L.P.Accelmed Part...,
  
• Douglas Strang,
  
• Samuel Rubinstein,
  
• Nachum Shamir,
  
• Christopher Lesovitz,
  Chief Financial Officer
• William D. Humphries,
  
• Uri Geiger,
  Director
• Wayne Cafran,
  
• Irit Yaniv,
  
• Patricia S Walker,
  
• Robert Joseph Moccia,
  Chief Executive Officer
• Lp22 Nw Fund, Lp22 Nw Fund ...,
  
• Shmuel Gov,
  COO